AIM: Mouse chow is commonly high in advanced glycation end-products, known contributors to diabetic nephropathy. The aim of this study was to evaluate if targeting of the AGE-RAGE axis was still effective in the context of a diet low in AGE content, which is more comparable to diets consumed by individuals with type 1 diabetes. METHODS: C57BL/6J wild-type and mice deficient in the receptor for AGEs (RAGE-KO) consumed a diet low in AGE content. Groups of mice were given (i) vehicle; (ii) streptozotocin; or (iii) streptozotocin + AGE lowering therapy (alagebrium chloride) and followed for 24 weeks. RESULTS: Diabetic mice had high urinary albumin excretion rates, hyperfiltration and release of urinary Kim-1, not seen in diabetic RAGE-KO mice. Diabetic mice also had renal fibrosis, measured by glomerulosclerosis, tubulointerstitial expansion, TGF-β1 and glomerular collagen-IV deposition which almost all improved by RAGE-KO or alagebium. Diabetic mice had a greater renal burden of AGEs and increased expression of renal specific PKC-α phosphorylation, which was improved in RAGE-KO mice, or those treated with alagebrium. CONCLUSION: Diabetic mice given a low-AGE diet still developed renal disease, which could be attenuated by targeting of the AGE-RAGE axis.
AIM: Mouse chow is commonly high in advanced glycation end-products, known contributors to diabetic nephropathy. The aim of this study was to evaluate if targeting of the AGE-RAGE axis was still effective in the context of a diet low in AGE content, which is more comparable to diets consumed by individuals with type 1 diabetes. METHODS: C57BL/6J wild-type and mice deficient in the receptor for AGEs (RAGE-KO) consumed a diet low in AGE content. Groups of mice were given (i) vehicle; (ii) streptozotocin; or (iii) streptozotocin + AGE lowering therapy (alagebrium chloride) and followed for 24 weeks. RESULTS:Diabeticmice had high urinary albumin excretion rates, hyperfiltration and release of urinary Kim-1, not seen in diabetic RAGE-KOmice. Diabeticmice also had renal fibrosis, measured by glomerulosclerosis, tubulointerstitial expansion, TGF-β1 and glomerular collagen-IV deposition which almost all improved by RAGE-KO or alagebium. Diabeticmice had a greater renal burden of AGEs and increased expression of renal specific PKC-α phosphorylation, which was improved in RAGE-KO mice, or those treated with alagebrium. CONCLUSION:Diabeticmice given a low-AGE diet still developed renal disease, which could be attenuated by targeting of the AGE-RAGE axis.
Authors: Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight Journal: J Surg Res Date: 2014-04-08 Impact factor: 2.192
Authors: Neal X Chen; Shruthi Srinivasan; Kalisha O'Neill; Thomas L Nickolas; Joseph M Wallace; Matthew R Allen; Corinne E Metzger; Amy Creecy; Keith G Avin; Sharon M Moe Journal: J Bone Miner Res Date: 2019-12-30 Impact factor: 6.390
Authors: Robert J Anderberg; Rick L Meek; Kelly L Hudkins; Sheryl K Cooney; Charles E Alpers; Renee C Leboeuf; Katherine R Tuttle Journal: Lab Invest Date: 2014-12-22 Impact factor: 5.662
Authors: Vicki Thallas-Bonke; Jay C Jha; Stephen P Gray; David Barit; Hermann Haller; Harald H H W Schmidt; Melinda T Coughlan; Mark E Cooper; Josephine M Forbes; Karin A M Jandeleit-Dahm Journal: Physiol Rep Date: 2014-11-03
Authors: Emmanuelle Charrin; Camille Faes; Amandine Sotiaux; Sarah Skinner; Vincent Pialoux; Philippe Joly; Philippe Connes; Cyril Martin Journal: Front Physiol Date: 2019-07-23 Impact factor: 4.566